AUA 0 3 0 3 B-clinical_variable
score 4 9 4 9 I-clinical_variable
must 10 14 10 14 O
be 15 17 15 17 O
≤20 18 21 18 21 O

Adenocarcinoma 0 14 22 36 B-cancer
of 15 17 37 39 O
the 18 21 40 43 O
prostate 22 30 44 52 O

Age 0 3 53 56 B-age
≥18 4 7 57 60 O

Agreement 0 9 61 70 B-contraception_consent
to 10 12 71 73 I-contraception_consent
use 13 16 74 77 I-contraception_consent
effective 17 26 78 87 I-contraception_consent
contraceptive 27 40 88 101 I-contraception_consent
methods 41 48 102 109 I-contraception_consent
such 49 53 110 114 O
as 54 56 115 117 O
condom 57 63 118 124 O
/ 63 64 124 125 O
diaphragm 64 73 125 134 O
and 74 77 135 138 O
spermicidal 78 89 139 150 O
foam 90 94 151 155 O
, 94 95 155 156 O
intrauterine 96 108 157 169 O
device 109 115 170 176 O
, 115 116 176 177 O
or 117 119 178 180 O
prescription 120 132 181 193 O
birth 133 138 194 199 O
control 139 146 200 207 O
pills 147 152 208 213 O

CT 0 2 214 216 B-clinical_variable
or 3 5 217 219 I-clinical_variable
Ultrasound 6 16 220 230 I-clinical_variable
- 16 17 230 231 I-clinical_variable
based 17 22 231 236 I-clinical_variable
volume 23 29 237 243 I-clinical_variable
estimation 30 40 244 254 I-clinical_variable
of 41 43 255 257 I-clinical_variable
prostate 44 52 258 266 I-clinical_variable
gland 53 58 267 272 I-clinical_variable
≤80 59 62 273 276 O
grams 63 68 277 282 I-upper_bound

Clinically 0 10 283 293 O
eligible 11 19 294 302 O
for 20 23 303 306 O
rectal 24 30 307 313 B-treatment
spacer 31 37 314 320 I-treatment
insertion 38 47 321 330 I-treatment
( 48 49 331 332 O
e.g. 49 53 332 336 O
Duraseal 54 62 337 345 B-treatment
, 62 63 345 346 O
SpaceOAR 64 72 347 355 B-treatment
, 72 73 355 356 O
or 74 76 357 359 O
equivalent 77 87 360 370 O
product 88 95 371 378 O
) 95 96 378 379 O
per 97 100 380 383 O
physician 101 110 384 393 O
evaluation 111 121 394 404 O

Clinically 0 10 405 415 O
negative 11 19 416 424 O
lymph 20 25 425 430 O
nodes 26 31 431 436 O
as 32 34 437 439 O
established 35 46 440 451 O
by 47 49 452 454 O
imaging 50 57 455 462 O
( 58 59 463 464 O
abdominal 59 68 464 473 B-treatment
and 69 72 474 477 I-treatment
pelvic 73 79 478 484 I-treatment
CT 80 82 485 487 I-treatment
or 83 85 488 490 O
abdominal 86 95 491 500 B-treatment
and 96 99 501 504 I-treatment
pelvic 100 106 505 511 I-treatment
MRI 107 110 512 515 I-treatment
) 110 111 515 516 O
, 111 112 516 517 O
nodal 113 118 518 523 B-treatment
sampling 119 127 524 532 I-treatment
, 127 128 532 533 O
or 129 131 534 536 O
dissection 132 142 537 547 B-treatment
within 143 149 548 554 O
90 150 152 555 557 B-upper_bound
days 153 157 558 562 I-upper_bound
prior 158 163 563 568 I-upper_bound
to 164 166 569 571 O
registration 167 179 572 584 O

Concomitant 0 11 585 596 O
antineoplastic 12 26 597 611 B-treatment
therapy 27 34 612 619 I-treatment
( 35 36 620 621 O
including 36 45 621 630 O
surgery 46 53 631 638 B-treatment
, 53 54 638 639 O
cryotherapy 55 66 640 651 B-treatment
, 66 67 651 652 O
conventionally 68 82 653 667 B-treatment
fractionated 83 95 668 680 I-treatment
radiotherapy 96 108 681 693 I-treatment
, 108 109 693 694 O
and 110 113 695 698 O
chemotherapy 114 126 699 711 B-treatment
) 126 127 711 712 O
while 128 133 713 718 O
on 134 136 719 721 O
this 137 141 722 726 O
protocol 142 150 727 735 O

Deemed 0 6 736 742 O
eligible 7 15 743 751 O
for 16 19 752 755 O
Complete 20 28 756 764 B-treatment
Androgen 29 37 765 773 I-treatment
Blockade 38 46 774 782 I-treatment
( 47 48 783 784 I-treatment
CAB 48 51 784 787 I-treatment
) 51 52 787 788 I-treatment
hormone 53 60 789 796 I-treatment
therapy 61 68 797 804 I-treatment
by 69 71 805 807 O
treating 72 80 808 816 O
physician 81 90 817 826 O
, 90 91 826 827 O
including 92 101 828 837 O
baseline 102 110 838 846 O
liver 111 116 847 852 O
function 117 125 853 861 O
evaluation 126 136 862 872 O

Equivocal 0 9 873 882 B-treatment
bone 10 14 883 887 I-treatment
scan 15 19 888 892 I-treatment
findings 20 28 893 901 O
are 29 32 902 905 O
allowed 33 40 906 913 O
if 41 43 914 916 O
plain 44 49 917 922 O
films 50 55 923 928 O
are 56 59 929 932 O
negative 60 68 933 941 O
for 69 72 942 945 O
metastasis 73 83 946 956 B-cancer

Evidence 0 8 957 965 O
of 9 11 966 968 O
metastatic 12 22 969 979 B-cancer
disease 23 30 980 987 I-cancer
by 31 33 988 990 O
imaging 34 41 991 998 O
study 42 47 999 1004 O

For 0 3 1005 1008 O
patients 4 12 1009 1017 O
not 13 16 1018 1021 O
eligible 17 25 1022 1030 O
for 26 29 1031 1034 O
anti 30 34 1035 1039 B-treatment
- 34 35 1039 1040 I-treatment
testosterone 35 47 1040 1052 I-treatment
therapy 48 55 1053 1060 I-treatment
, 55 56 1060 1061 O
hormone 57 64 1062 1069 B-treatment
therapy 65 72 1070 1077 I-treatment
with 73 77 1078 1082 I-treatment
LHRH 78 82 1083 1087 I-treatment
agonist 83 90 1088 1095 I-treatment
alone 91 96 1096 1101 O
will 97 101 1102 1106 O
be 102 104 1107 1109 O
permitted 105 114 1110 1119 O
on 115 117 1120 1122 O
case 118 122 1123 1127 O
by 123 125 1128 1130 O
case 126 130 1131 1135 O
basis 131 136 1136 1141 O
by 137 139 1142 1144 O
study 140 145 1145 1150 O
P.I 146 149 1151 1154 O

Histologic 0 10 1155 1165 O
confirmation 11 23 1166 1178 O
of 24 26 1179 1181 O
cancer 27 33 1182 1188 B-cancer
by 34 36 1189 1191 O
biopsy 37 43 1192 1198 B-treatment

History 0 7 1199 1206 O
of 8 10 1207 1209 O
Crohn 11 16 1210 1215 B-chronic_disease
's 16 18 1215 1217 I-chronic_disease
Disease 19 26 1218 1225 I-chronic_disease
or 27 29 1226 1228 O
Ulcerative 30 40 1229 1239 B-chronic_disease
Colitis 41 48 1240 1247 I-chronic_disease

MR 0 2 1248 1250 B-cancer
stage 3 8 1251 1256 I-cancer
T3a 9 12 1257 1260 I-cancer
without 13 20 1261 1268 O
other 21 26 1269 1274 O
high 27 31 1275 1279 O
risk 32 36 1280 1284 O
factors 37 44 1285 1292 O
permitted 45 54 1293 1302 O
at 55 57 1303 1305 O
investigator 58 70 1306 1318 O
discretion 71 81 1319 1329 O

Men 0 3 1330 1333 B-gender
of 4 6 1334 1336 O
reproductive 7 19 1337 1349 O
potential 20 29 1350 1359 O
may 30 33 1360 1363 O
not 34 37 1364 1367 O
participate 38 49 1368 1379 O
unless 50 56 1380 1386 O
they 57 61 1387 1391 O
agree 62 67 1392 1397 B-contraception_consent
to 68 70 1398 1400 I-contraception_consent
use 71 74 1401 1404 I-contraception_consent
an 75 77 1405 1407 I-contraception_consent
effective 78 87 1408 1417 I-contraception_consent
contraceptive 88 101 1418 1431 I-contraception_consent
method 102 108 1432 1438 I-contraception_consent

No 0 2 1439 1441 O
direct 3 9 1442 1448 O
evidence 10 18 1449 1457 O
of 19 21 1458 1460 O
regional 22 30 1461 1469 O
or 31 33 1470 1472 O
distant 34 41 1473 1480 O
metastases 42 52 1481 1491 B-cancer
after 53 58 1492 1497 O
appropriate 59 70 1498 1509 O
staging 71 78 1510 1517 O
studies 79 86 1518 1525 O
as 87 89 1526 1528 O
indicated 90 99 1529 1538 O
clinically 100 110 1539 1549 O

No 0 2 1550 1552 O
distant 3 10 1553 1560 O
metastases 11 21 1561 1571 B-cancer
( 22 23 1572 1573 I-cancer
M0 23 25 1573 1575 I-cancer
) 25 26 1575 1576 I-cancer
on 27 29 1577 1579 O
bone 30 34 1580 1584 B-treatment
scan 35 39 1585 1589 I-treatment
within 40 46 1590 1596 O
90 47 49 1597 1599 B-upper_bound
days 50 54 1600 1604 I-upper_bound
prior 55 60 1605 1610 I-upper_bound
to 61 63 1611 1613 O
registration 64 76 1614 1626 O

No 0 2 1627 1629 O
known 3 8 1630 1635 O
allergies 9 18 1636 1645 O
to 19 21 1646 1648 O
spacer 22 28 1649 1655 B-allergy_name
material 29 37 1656 1664 I-allergy_name
: 37 38 1664 1665 O
Polyethylene 39 51 1666 1678 B-allergy_name
glycol 52 58 1679 1685 I-allergy_name
( 59 60 1686 1687 I-allergy_name
PEG 60 63 1687 1690 I-allergy_name
) 63 64 1690 1691 I-allergy_name
hydrogel 65 73 1692 1700 I-allergy_name

No 0 2 1701 1703 O
nodal 3 8 1704 1709 B-cancer
disease 9 16 1710 1717 I-cancer

Not 0 3 1718 1721 O
actively 4 12 1722 1730 O
on 13 15 1731 1733 O
immunosuppressive 16 33 1734 1751 B-treatment
medications 34 45 1752 1763 I-treatment

OR 0 2 1764 1766 O
Gleason 3 10 1767 1774 B-clinical_variable
score 11 16 1775 1780 I-clinical_variable
≥ 17 18 1781 1782 O
8 19 20 1783 1784 B-lower_bound

PSA 0 3 1785 1788 B-clinical_variable
≥20 4 7 1789 1792 O

Positive 0 8 1793 1801 B-cancer
lymph 9 14 1802 1807 I-cancer
nodes 15 20 1808 1813 I-cancer
or 21 23 1814 1816 O
metastatic 24 34 1817 1827 B-cancer
disease 35 42 1828 1835 I-cancer
from 43 47 1836 1840 O
prostate 48 56 1841 1849 B-cancer
cancer 57 63 1850 1856 I-cancer
by 64 66 1857 1859 O
imaging 67 74 1860 1867 O
studies 75 82 1868 1875 O
( 83 84 1876 1877 O
CT 84 86 1877 1879 B-treatment
or 87 89 1880 1882 O
MRI 90 93 1883 1886 B-treatment
) 93 94 1886 1887 O
, 94 95 1887 1888 O
unless 96 102 1889 1895 O
biopsy 103 109 1896 1902 B-treatment
proven 110 116 1903 1909 O
to 117 119 1910 1912 O
be 120 122 1913 1915 O
negative 123 131 1916 1924 O

Previous 0 8 1925 1933 O
androgen 9 17 1934 1942 B-treatment
depravation 18 29 1943 1954 I-treatment
therapy 30 37 1955 1962 I-treatment
given 38 43 1963 1968 O
for 44 47 1969 1972 O
more 48 52 1973 1977 O
than 53 57 1978 1982 O
9 58 59 1983 1984 B-lower_bound
months 60 66 1985 1991 I-lower_bound
prior 67 72 1992 1997 I-lower_bound
to 73 75 1998 2000 O
therapy 76 83 2001 2008 O

Previous 0 8 2009 2017 O
pelvic 9 15 2018 2024 B-treatment
radiotherapy 16 28 2025 2037 I-treatment

Previous 0 8 2038 2046 O
surgery 9 16 2047 2054 B-treatment
or 17 19 2055 2057 O
chemotherapy 20 32 2058 2070 B-treatment
for 33 36 2071 2074 O
prostate 37 45 2075 2083 B-cancer
cancer 46 52 2084 2090 I-cancer

Previous 0 8 2091 2099 O
transuretheral 9 23 2100 2114 B-treatment
resection 24 33 2115 2124 I-treatment
of 34 36 2125 2127 I-treatment
the 37 40 2128 2131 I-treatment
prostate 41 49 2132 2140 I-treatment
( 50 51 2141 2142 I-treatment
TURP 51 55 2142 2146 I-treatment
) 55 56 2146 2147 I-treatment
or 57 59 2148 2150 O
cryotherapy 60 71 2151 2162 B-treatment
to 72 74 2163 2165 O
the 75 78 2166 2169 O
prostate 79 87 2170 2178 O

Prior 0 5 2179 2184 O
invasive 6 14 2185 2193 O
malignancy 15 25 2194 2204 B-cancer
unless 26 32 2205 2211 O
disease 33 40 2212 2219 O
free 41 45 2220 2224 O
for 46 49 2225 2228 O
a 50 51 2229 2230 O
minimum 52 59 2231 2238 O
of 60 62 2239 2241 O
3 63 64 2242 2243 B-upper_bound
years 65 70 2244 2249 I-upper_bound

Significant 0 11 2250 2261 O
psychiatric 12 23 2262 2273 B-chronic_disease
illness 24 31 2274 2281 I-chronic_disease

Ultrasound 0 10 2282 2292 B-treatment
or 11 13 2293 2295 O
CT 14 16 2296 2298 B-treatment
estimate 17 25 2299 2307 B-clinical_variable
of 26 28 2308 2310 I-clinical_variable
prostate 29 37 2311 2319 I-clinical_variable
volume 38 44 2320 2326 I-clinical_variable
> 45 46 2327 2328 O
80 47 49 2329 2331 B-lower_bound
grams 50 55 2332 2337 I-lower_bound

Use 0 3 2338 2341 O
of 4 6 2342 2344 O
previous 7 15 2345 2353 B-treatment
hormonal 16 24 2354 2362 I-treatment
therapy 25 32 2363 2370 I-treatment
for 33 36 2371 2374 O
up 37 39 2375 2377 O
to 40 42 2378 2380 O
9 43 44 2381 2382 B-upper_bound
months 45 51 2383 2389 I-upper_bound
is 52 54 2390 2392 O
allowed 55 62 2393 2400 O
for 63 66 2401 2404 O
the 67 70 2405 2408 O
treatment 71 80 2409 2418 B-treatment
of 81 83 2419 2421 O
prostate 84 92 2422 2430 B-cancer
cancer 93 99 2431 2437 I-cancer
as 100 102 2438 2440 O
well 103 107 2441 2445 O
as 108 110 2446 2448 O
for 111 114 2449 2452 O
prostate 115 123 2453 2461 O
volume 124 130 2462 2468 O
reduction 131 140 2469 2478 O

Zubrod 0 6 2479 2485 B-clinical_variable
Performance 7 18 2486 2497 I-clinical_variable
Status 19 25 2498 2504 I-clinical_variable
0 26 27 2505 2506 B-lower_bound
- 27 28 2506 2507 O
2 28 29 2507 2508 B-upper_bound

alpha 0 5 2509 2514 B-treatment
blockers 6 14 2515 2523 I-treatment

non 0 3 2524 2527 B-cancer
- 3 4 2527 2528 I-cancer
melanomatous 4 16 2528 2540 I-cancer
skin 17 21 2541 2545 I-cancer
cancer 22 28 2546 2552 I-cancer

repeat 0 6 2553 2559 O
ultrasound 7 17 2560 2570 B-treatment
measurement 18 29 2571 2582 O
after 30 35 2583 2588 O
hormone 36 43 2589 2596 O
downsizing 44 54 2597 2607 O

